FDA adds two behavioral health firms to TEMPO pilot

The FDA has added two behavioral health companies, Limbic and Sondermind, to its TEMPO pilot, allowing evaluation of digital health devices for anxiety and depression without premarket authorization requirements. Limbic offers an AI-driven cognitive behavioral therapy service, aiming to address mental health professional shortages.

This Wire brief sits within Fusion42's coverage of Digital Health.